Light AI Inc.
Market Cap: Private
- LightAI is developing a technology platform which represents the “Holy Grail” of nextgen diagnostics: it applies AI algorithms to smartphone images–starting with images of StrepA—to identify disease in seconds. No swabs, lab tests or proprietary hardware of any kind required.
- Companies like GoogleHealth have talked about the Holy Grail of smartphone diagnostics for years, but still talk about it as if its years out. LightAI’s algorithm has already attained an NPV (Negative Predictive Value) of 100% and accuracy of almost 97% in identifying StrepA, a disease which infects over 600M per year globally, and kills as many children per year as malaria.